Lung Cancer Treatment Market By Treatment Type (Medications {Cytotoxic Drugs, Tyrosine Kinase Inhibitors (TKIs), Others}, Surgical Procedures {Lobectomy, Pneumonectomy, Segmentectomy, Others}, Radiation Therapy {External Beam Radiation Therapy (EBRT), Brachytherapy, Others}, Chemotherapy {Platinum-Based Agents, Antimetabolites, Others}, Immunotherapy, Others), By Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), By Route of Administration (Oral, Intravenous, Inhalation, Others), and By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Medications
  • Cytotoxic Drugs
  • Tyrosine Kinase Inhibitors (TKIs)
  • Others
• Surgical Procedures
  • Lobectomy
  • Pneumonectomy
  • Segmentectomy
  • Others
• Radiation Therapy
  • External Beam Radiation Therapy (EBRT)
  • Brachytherapy
  • Others
• Chemotherapy
  • Platinum-Based Agents
  • Antimetabolites
  • Others
• Immunotherapy
• Others

By Cancer Type

• Non-Small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer (SCLC)

By Route of Administration

• Oral
• Intravenous
• Inhalation
• Others

By End-User

• Hospitals
• Specialty Clinics
• Cancer Research Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Roche
• Bristol-Myers Squibb
• Merck & Co.
• AstraZeneca
• Eli Lilly and Company
• Pfizer
• Novartis
• Amgen
• Bayer
• Johnson & Johnson
• Sanofi
• AbbVie
• Gilead Sciences
• Takeda Pharmaceutical
• Regeneron Pharmaceuticals